First Cases for Acclarent TruDi ENT Navigation System

« Back to Industry News


J&J’s Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat (ENT) technologies, has announced the U.S. commercial launch of TruDi, a real-time, three-dimensional (3D) navigation system for ENT procedures performed in the operating room and surgeon office.

Acclarent developed TruDi in collaboration with Biosense Webster, Inc., well known on our pages as a specialist in heart rhythm disorders. TruDi leverages Biosense Webster’s advanced imaging system which uses electromagnetic technologies to help electrophysiologists navigate the beating heart by generating an accurate map, and pinpoints the exact location and orientation of catheters used during diagnostic and therapeutic procedures.

TruDi is an electromagnetic image-guided navigation system designed to offer ENT surgeons an accurate, simple and reliable option for their endoscopic sinus surgery procedures. It is intended for use during intranasal and paranasal image-guided navigation procedures for eligible patients requiring sinus surgery. TruDi enables the use of RELIEVA SPINPLUS® NAV, the first 3D navigation-enabled Balloon Sinuplasty System for the treatment of chronic sinusitis.

Acclarent’s TruDi Navigation System recently received U.S. FDA 510(k) clearance, and first cases were completed Monday, April 16th at two leading U.S. healthcare facilities.

Click here to view the full related article.

« Back to Industry News